Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:49 AM
Ignite Modification Date:
2025-12-25 @ 3:49 AM
NCT ID:
NCT02582502
Eligibility Criteria:
Inclusion Criteria:
1. Age between 19 and 85.
2. Able to speak English and give informed consent or have a substitute decision maker and able to assent.
3. One or more ischemic stroke(s) involving the cerebral cortex or cerebellum within the last 6 to 36 months
4. Able to sit in the chamber with the assistance of a waist and chest strap for 120 minutes.
Exclusion Criteria:
1. Contraindication to HBOT (Appendix C) including:
1. Untreated collapsed lung (pneumothorax)
2. Have taken the chemotherapy drug Doxorubicin within 72 hours
3. Have taken the chemotherapy drug Bleomycin within 4 months
4. Bowel obstruction
5. Heart pacemaker of unknown make and model
6. Pregnancy
7. Cigarette Smoking
8. Chronic Obstructive Pulmonary Disease (COPD)
2. Participation in other stroke related studies.
3. Previous history stroke \> 36 months prior to study baseline
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
85 Years
Study:
NCT02582502
Study Brief:
Protocol Section:
NCT02582502